Terms: = Lung cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C AND Prognosis
18 results:
1. Tyrosine phosphatase
Chen X; Keller SJ; Hafner P; Alrawashdeh AY; Avery TY; Norona J; Zhou J; Ruess DA
Front Immunol; 2024; 15():1340726. PubMed ID: 38504984
[TBL] [Abstract] [Full Text] [Related]
2. Re-expression of epigenetically silenced PTPRR by histone acetylation sensitizes RAS-mutant lung adenocarcinoma to shp2 inhibition.
Du T; Hu X; Hou Z; Wang W; You S; Wang M; Ji M; Xue N; Chen X
Cell Mol Life Sci; 2024 Jan; 81(1):64. PubMed ID: 38280930
[TBL] [Abstract] [Full Text] [Related]
3. RNA-Seq Analysis Reveals Altered Expression of Cell Adhesion-Related Genes Following PZR Knockout in lung cancer Cells.
Fu Y; Li G; Fu X; Xing S; Zhao ZJ
Appl Biochem Biotechnol; 2024 Apr; 196(4):2122-2136. PubMed ID: 37470934
[TBL] [Abstract] [Full Text] [Related]
4. A pan-cancer analysis confirms ptpn11's potential as a prognostic and immunological biomarker.
Cao Y; Duan H; Su A; Xu L; Lai B
Aging (Albany NY); 2022 Jul; 14(13):5590-5610. PubMed ID: 35802774
[TBL] [Abstract] [Full Text] [Related]
5. Gene network Analysis Defines a Subgroup of Small Cell lung cancer patients With Short Survival.
Cucchiara F; Petrini I; Passaro A; Attili I; Crucitta S; Pardini E; de Marinis F; Danesi R; Del Re M
Clin Lung Cancer; 2022 Sep; 23(6):510-521. PubMed ID: 35739016
[TBL] [Abstract] [Full Text] [Related]
6. TGF-β1/SH2B3 axis regulates anoikis resistance and EMT of lung cancer cells by modulating JAK2/STAT3 and shp2/Grb2 signaling pathways.
Wang LN; Zhang ZT; Wang L; Wei HX; Zhang T; Zhang LM; Lin H; Zhang H; Wang SQ
Cell Death Dis; 2022 May; 13(5):472. PubMed ID: 35589677
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic significance of shp2 (ptpn11) expression in solid tumors: A meta-analysis.
Zhou J; Guo H; Zhang Y; Liu H; Dou Q
PLoS One; 2022; 17(1):e0262931. PubMed ID: 35061863
[TBL] [Abstract] [Full Text] [Related]
8. cancer cell-derived exosomal circUSP7 induces CD8
Chen SW; Zhu SQ; Pei X; Qiu BQ; Xiong D; Long X; Lin K; Lu F; Xu JJ; Wu YB
Mol Cancer; 2021 Nov; 20(1):144. PubMed ID: 34753486
[TBL] [Abstract] [Full Text] [Related]
9. Which N Descriptor Is More Predictive of prognosis in Resected Non-small Cell lung cancer: The Number of Involved Nodal Stations or the Location-Based Pathological N Stage?
Xu L; Su H; She Y; Dai C; Zhao M; Gao J; Xie H; Ren Y; Xie D; Chen C
Chest; 2021 Jun; 159(6):2458-2469. PubMed ID: 33352193
[TBL] [Abstract] [Full Text] [Related]
10. Molecular Nodal Restaging Based on CEACAM5, FGFR2b and ptpn11 Expression Adds No Relevant Clinical Information in Resected Non-Small Cell lung cancer.
Macia I; Aiza G; Ramos R; Escobar I; Rivas F; Ureña A; Aso S; Rosado G; Rodriguez-Taboada P; Deniz C; Nadal E; Capella G
J Invest Surg; 2022 Feb; 35(2):315-324. PubMed ID: 33342327
[TBL] [Abstract] [Full Text] [Related]
11. The clinicopathological and prognostic implications of tyrosine phosphatase shp2 and ankyrin Hook1 gene expression in non- small cell lung cancer patients treated with gemcitabine plus platinum as first-line chemotherapy.
Yang H; He L; Zhang Y; Li Y; Huang X; Li Y; Lou Y; Wang L
Ann Palliat Med; 2020 Sep; 9(5):2943-2952. PubMed ID: 32819122
[TBL] [Abstract] [Full Text] [Related]
12. Association of nuclear localization of shp2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
[TBL] [Abstract] [Full Text] [Related]
13. Diagnostic and prognostic value of serum Cripto-1 in patients with non-small cell lung cancer.
Xu CH; Chi CZ; Zhang Q; Wang YC; Wang W; Yuan Q; Zhan P; Zhang XW; Lin Y
Clin Respir J; 2018 Oct; 12(10):2469-2474. PubMed ID: 29570945
[TBL] [Abstract] [Full Text] [Related]
14. Dioscin overcome TKI resistance in EGFR-mutated lung adenocarcinoma cells via down-regulation of tyrosine phosphatase shp2 expression.
Wang YC; Wu DW; Wu TC; Wang L; Chen CY; Lee H
Int J Biol Sci; 2018; 14(1):47-56. PubMed ID: 29483824
[TBL] [Abstract] [Full Text] [Related]
15. shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798.
Yang X; Tang C; Luo H; Wang H; Zhou X
Oncotarget; 2017 Apr; 8(14):23664-23674. PubMed ID: 28423588
[TBL] [Abstract] [Full Text] [Related]
16. ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells.
Liu X; Yu X; Xie J; Zhan M; Yu Z; Xie L; Zeng H; Zhang F; Chen G; Yi X; Zheng J
Oncotarget; 2015 Aug; 6(25):21004-15. PubMed ID: 26056041
[TBL] [Abstract] [Full Text] [Related]
17. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
Mainou-Fowler T; Overman LM; Dignum H; Wood K; Crosier S; Angus B; Proctor SJ; Anderson JJ
Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
[TBL] [Abstract] [Full Text] [Related]
